期刊文献+

以皮疹为首发表现的真性红细胞增多症1例

下载PDF
导出
摘要 真性红细胞增多症(polyeythemia vera,PV)为发病率较低的造血系统疾病。其造血干/祖细胞具有异常克隆性、高增殖性及低凋亡性。临床表现以红细胞增多为主的两系或三系血细胞增多。以及由此引起的血液粘滞表现.其有转化为骨髓纤维化或白血病。的风险。以皮肤病为首发表现的PV病例较少见,现报道1例。
作者 吴昊 马英
机构地区 上海市华山医院
出处 《中国麻风皮肤病杂志》 2013年第9期591-593,共3页 China Journal of Leprosy and Skin Diseases
  • 相关文献

参考文献7

  • 1白洁,邵宗鸿.真性红细胞增多症造血干及祖细胞生物学特征的研究进展[J].中华内科杂志,2002,41(2):140-142. 被引量:14
  • 2Levine RL, Wadleish M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polyeythemia vera, essential throm- bocythemia,and myeloid metaplasia with myelofibrosis. Cancer Cell, 2005,7 (4) : 387- 397.
  • 3Najean Y, Dresch C, Rain JD. The very-long term course of polyeythaemia vera a complement to the previously published da- ta of the polyeythaemia vera study group. Br J Haematol, 1994, 86( 1 ) :233-235.
  • 4Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary my- elofibrosis: recommendations from an ad hoc international expert panel. Blood ,2007,110(4) : 1092-1097.
  • 5姚贵申 王盛绪.真性红细胞增多症皮肤黏膜改变八例[J].中华皮肤科杂志,1994,27(6):388-388.
  • 6Mesa RA. Navigating the evolving paradigms in the diagnosis and treatment of myeloproliferative disorders. Hematology Am Soc Hematol Educ Program,2007,355-362.
  • 7Wernig G, Kharas MG, Okabe R, et al. Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer Ce11,2008, 13 (4) :311-320.

二级参考文献20

  • 1Kralovics R,Indrak K,Stopka T, et al. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood, 1997,90:2057-2061.
  • 2Chiba S, Takahashi T, Takeshita K, et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood, 1997, 90:97-104.
  • 3Le Couedic JP, Mitjavila MT, Villeval JL, et al. Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood, 1996, 87:1502-1511.
  • 4Yan XQ, Lacey D, Fletcher F,et al. Chronic expossure to retroviral vector encoded MGDF(mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood, 1995, 86:4025-4033.
  • 5Kieran MW, Perkins AC, Orkin SH, et al. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA, 1996, 93:9126-9131.
  • 6Ratajczak MZ, Ratajczak J, Marlicz W, et al. Recombinant human thrombopoietin(TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis. Br J Haematol, 1997,98:8-18.
  • 7Moliterno AR, Hankins, WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med, 1998,338:572-580.
  • 8Moliterno AR, Spivak JL. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood,1999,94:2555-2561.
  • 9Le Blanc K, Andersson P, Samuelsson J. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera. Br J Haematol, 2000,108:80-85.
  • 10Temerinac S, Klippel S,Struck E, et al. Cloning of PRV-1,a novel member of the uPAR receptor superfamily ,which is overexpressed in polycythemia rubra vera. Blood, 2000,95:2569-2576.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部